Clinical Trials
3 trialsNCT03940352 2025-10-10
HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)
Novartis
Phase 1 Terminated
NCT05447663 2025-05-16
A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant
Novartis
Phase 1/2 Terminated
NCT04496999 2022-10-06
HDMM
Insel Gruppe AG, University Hospital Bern
Phase 1 Terminated